Infectious Diseases Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Infectious Diseases stocks.

Infectious Diseases Stocks Recent News

Date Stock Title
Nov 22 NVS Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View
Nov 22 NVS Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics
Nov 22 NVS Novartis provides updates to mid-term guidance, now sees 6% sales CAGR 2023-2028
Nov 22 NVS Novartis acquires Kate Therapeutics to advance gene therapies
Nov 21 NVS Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
Nov 21 NVS Novartis buys gene therapy developer Kate for up to $1.1B
Nov 21 NVS Novartis raises mid-term sales guidance
Nov 21 HROW Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.
Nov 21 NVS Novartis Lifts Midterm Sales Guidance Amid U.S. Expansion
Nov 21 NVS Novartis wagers more than $1B on gene therapies for the nervous system
Nov 21 NVS Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth
Nov 20 HROW Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery
Nov 19 TVGN Tevogen Bio Holdings reports Q3 results
Nov 19 TVGN Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model
Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
Nov 19 NVS Novartis strengthens radiopharma leadership with Ratio Therapeutics deal
Nov 19 NVS Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
Nov 19 VIR Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program
Nov 18 NVS Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer
Nov 18 VIR Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines Agency
Infectious Diseases

Infection is the invasion of an organism's body tissues by disease-causing agents, their multiplication, and the reaction of host tissues to the infectious agents and the toxins they produce. Infectious disease, also known as transmissible disease or communicable disease, is illness resulting from an infection.
Infections are caused by infectious agents including viruses, viroids, prions, bacteria, nematodes such as parasitic roundworms and pinworms, arthropods such as ticks, mites, fleas, and lice, fungi such as ringworm, and other macroparasites such as tapeworms and other helminths.
Hosts can fight infections using their immune system. Mammalian hosts react to infections with an innate response, often involving inflammation, followed by an adaptive response.Specific medications used to treat infections include antibiotics, antivirals, antifungals, antiprotozoals, and antihelminthics. Infectious diseases resulted in 9.2 million deaths in 2013 (about 17% of all deaths). The branch of medicine that focuses on infections is referred to as infectious disease.

Browse All Tags